Inventor
BURNSIDE BETH A
US37 patents
⚠️ This page may combine multiple inventors who share the name “BURNSIDE BETH A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE LAB INC
19 patentsUS6913768B2Jul 5, 2005
Sustained release delivery of amphetamine salts
SHIRE LAB INC266 citations98
US6605300B1Aug 12, 2003
Oral pulsed dose drug delivery system
SHIRE LAB INC118 citations98
US6287599B1Sep 11, 2001
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
SHIRE LAB INC216 citations98
US6811794B2Nov 2, 2004
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
SHIRE LAB INC105 citations97
US6692767B2Feb 17, 2004
Solid solution beadlet
SHIRE LAB INC88 citations97
US6361796B1Mar 26, 2002
Soluble form osmotic dose delivery system
SHIRE LAB INC87 citations97
US6322819B1Nov 27, 2001
Oral pulsed dose drug delivery system
SHIRE LAB INC348 citations97
US6284276B1Sep 4, 2001
Soluble form osmotic dose delivery system
SHIRE LAB INC106 citations97
US6110498AAug 29, 2000
Osmotic drug delivery system
SHIRE LAB INC118 citations97
US5824638AOct 20, 1998
Oral insulin delivery
SHIRE LAB INC190 citations97
US6814979B2Nov 9, 2004
Osmotic drug delivery system
SHIRE LAB INC61 citations96
US6514532B2Feb 4, 2003
Soluble form osmotic dose delivery system
SHIRE LAB INC43 citations96
US7011846B2Mar 14, 2006
Oral capsule formulation with increased physical stability
SHIRE LAB INC76 citations95
US5897876AApr 27, 1999
Emulsified drug delivery system
SHIRE LAB INC75 citations95
US6838093B2Jan 4, 2005
System for osmotic delivery of pharmaceutically active agents
SHIRE LAB INC54 citations92
US5883103AMar 16, 1999
Oral acyclovir delivery
SHIRE LAB INC31 citations91
US6793934B1Sep 21, 2004
Solid oral dosage form
SHIRE LAB INC27 citations89
US5948407ASep 7, 1999
Oral induction of tolerance to parenterally administered non-autologous polypeptides
SHIRE LAB INC32 citations88
US7022337B2Apr 4, 2006
Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect
SHIRE LAB INC17 citations82
BURNSIDE BETH A
7 patentsUS8460710B2Jun 11, 2013
Antibiotic product, use and formulation thereof
BURNSIDE BETH A3 citations60
US8062672B2Nov 22, 2011
Antibiotic product, use and formulation thereof
BURNSIDE BETH A2 citations60
US9144548B2Sep 29, 2015
Antibiotic product, use and formulation thereof
BURNSIDE BETH A0 citations49
US8425936B2Apr 23, 2013
Antibiotic product, use and formulation thereof
BURNSIDE BETH A0 citations39
US8313775B2Nov 20, 2012
Antibiotic product, use and formulation thereof
BURNSIDE BETH A0 citations39
US8313776B2Nov 20, 2012
Antibiotic product, use and formulation thereof
BURNSIDE BETH A0 citations39
US8246996B2Aug 21, 2012
Antibiotic product, use and formulation thereof
BURNSIDE BETH A0 citations39
FLANNER HENRY H
3 patentsUS8299052B2Oct 30, 2012
Pharmaceutical compositions and methods for improved bacterial eradication
FLANNER HENRY H1 citations42
US8778924B2Jul 15, 2014
Modified release amoxicillin products
FLANNER HENRY H0 citations32
US9125803B2Sep 8, 2015
Gastric release pulse system for drug delivery
FLANNER HENRY H0 citations30